Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

NCT01241760

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations
  • La Jolla, California, United States
  • Los Angeles, California, United States
  • San Diego, California, United States
  • Aurora, Colorado, United States
View all 99 locations
View Trial Details
Completed

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

NCT01329978

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Alabama Liver and Digestive Specialist Montgomery, Alabama, United States
  • Clopton Clinic Jonesboro, Arkansas, United States
  • Advanced Clinical Research Institute Anaheim, California, United States
  • Providence Clinical Research Burbank, California, United States
View all 46 locations
View Trial Details
Completed

An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy

NCT01281839

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Bakersfield, California, United States
  • Aurora, Colorado, United States
  • Jacksonville, Florida, United States
  • Orlando, Florida, United States
View all 68 locations
View Trial Details
Completed

Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

NCT01188772

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Alabama Liver and Digestive Specialists Montgomery, Alabama, United States
  • Advanced Clinical Research Institute Anaheim, California, United States
  • SCTI Research Foundation Coronado, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 23 locations
View Trial Details
Completed

Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients

NCT01054729

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Quest Clinical Research San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
  • Orlando Immunology Center Orlando, Florida, United States
  • Duke University Durham, North Carolina, United States
View Trial Details

Related conditions